Oxyberberine alleviates lipopolysaccharide-induced intestinal barrier disruption and inflammation in human colonic Caco-2 cells in vitro
BackgroundOxyberberine (OBB) is a naturally occurring isoquinoline alkaloid that is believed to possess various health-promoting properties, including anti-fungus, hepatoprotection, anti-inflammation, and anti-intestinal mucositis effects. Despite several studies reporting the health benefits of OBB...
Saved in:
| Main Authors: | Cailan Li, Jiahao Wang, Hongmei Yang, Shuang Luo, Qiang Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1496874/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hydroxyethyl starch-curcumin nanoparticles ameliorate DSS-induced ulcerative colitis in mice via synergistic TLR4/NF-κB suppression, Nrf2 activation, intestinal barrier restoration, and gut microbiota modulation
by: Sheng Li, et al.
Published: (2025-07-01) -
Scutellarein ameliorates dextran sulfate sodium-induced ulcerative colitis by inhibiting colonic epithelial cell proinflammation and barrier disruption
by: Qinglian Tang, et al.
Published: (2024-10-01) -
The protective effect of naringenin on ulcerative colitis in mice through increasing Nrf2 pathway activity
by: Li Jiaxiang, et al.
Published: (2025-03-01) -
Water-soluble garlic polysaccharide (WSGP) improves ulcerative colitis by modulating the intestinal barrier and intestinal flora metabolites
by: Xin Shao, et al.
Published: (2024-09-01) -
Cannabidiol Alleviates Intestinal Fibrosis in Mice with Ulcerative Colitis by Regulating Transforming Growth Factor Signaling Pathway
by: Wang Y, et al.
Published: (2025-01-01)